These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15078718)

  • 1. To infuse or not?
    Habet KJ
    Chest; 2004 Apr; 125(4):1182-3. PubMed ID: 15078718
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospital in the home.
    Montalto M
    Aust Fam Physician; 2011 Apr; 40(4):183, 185. PubMed ID: 21744523
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
    van Baalen A; von Spiczak S; Stephani U; Fischer G
    Neuromuscul Disord; 2008 Dec; 18(12):1005-6; author reply 1006. PubMed ID: 18952428
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
    Giamouzis G; Giannakoulas G; Tsarpalis K; Agha SA; Georgiopoulou V; Kalogeropoulos A; Karvounis H; Butler J
    Int J Cardiol; 2008 Aug; 128(1):91-3; author reply 94-6. PubMed ID: 18495268
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we use outpatient dobutamine or milrinone?
    Kato M; Sanada S; Kitakaze M
    Circ Heart Fail; 2009 Jul; 2(4):377-8. PubMed ID: 19808362
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
    Opasich C; Russo A; Mingrone R; Zambelli M; Tavazzi L
    Eur J Heart Fail; 2000 Mar; 2(1):7-11. PubMed ID: 10742697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy; dobutamine and milrinone].
    Kato M; Hirayama A
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():428-33. PubMed ID: 22724242
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical care. Inotrope therapy.
    Place B
    Nurs Times; 1996 Aug 28-Sep 3; 92(35):55-7. PubMed ID: 8868896
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F
    Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catecholamines use in patients with heart failure].
    Iino K; Ito H
    Nihon Rinsho; 2007 May; 65 Suppl 5():30-3. PubMed ID: 17571362
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Nanas JN; Tsagalou EP; Kanakakis J; Nanas SN; Terrovitis JV; Moon T; Anastasiou-Nana MI
    Chest; 2004 Apr; 125(4):1198-204. PubMed ID: 15078725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
    Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
    J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
    Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cul-de-sac at the end of the road.
    Stevenson LW
    J Card Fail; 2003 Jun; 9(3):188-91. PubMed ID: 12815568
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intravenous inotropic therapy in the home.
    McCloskey WW
    Am J Health Syst Pharm; 1998 May; 55(9):930-5; quiz 953-4. PubMed ID: 9588252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.